• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Earnings roundup: Insulet revenue jumps 36 percent as losses narrow

Earnings roundup: Insulet revenue jumps 36 percent as losses narrow

November 10, 2010 By MassDevice staff

MassDevice.com Earnings Roundup

Insulet revenue jumps 36 percent as losses narrow
Insulet Corp. (NSDQ:PODD) reported a loss of $12.1 million, or 30 cents per diluted share, on revenue of $25.5 million during the three months ended Sept. 30. That compares with a loss of $16.9 million, or 60 cents per diluted share, on revenue of $18.7 million during the same period last year.
Read more

Theragenics Corp. sales increase 6 percent, but profits weaken
Theragenics Corp. (NYSE:TGX) reported profits of approximately $771,000, or 2 cents per diluted share, on revenue of $20.4 million during the three months ended Sept. 30. That compares with profits of approximately $799,000, or 2 cents per diluted share, on revenue of $19.0 million during the same period last year.
Read more

Accellent losses nearly quadruple
Accellent Holdings Corp. subsidiary Accellent Inc. posted a loss of $3.1 million on sales of $125.0 million during the three months ended Sept. 30. That compares with a net loss of approximately $820,000 on sales of $117.8 million during the same period last year.
Read more

Losses outstrip revenue at NMT Medical
NMT Medical Inc. (NSDQ:NMTI) posted a loss of $3.4 million, or 21 cents per diluted share, on sales of $2.1 million during the three months ended Sept. 30. That compares with a loss of $2.9 million, or 22 cents per diluted share, on sales of $3.0 million during the same period last year.
Read more

Angiotech losses increase as revenue drops
Angiotech Pharmaceuticals Inc. (NSDQ:ANPI) reported a net loss of $18.5 million, or 22 cents per diluted share, on sales of $59.0 million during the three months ended Sept. 30. That compares with a loss of $7.8 million, or 9 cents per diluted share, on sales of $63.2 million during the same period last year.
Read more

Bovie Medical squeaks out a profit
Bovie Medical Corp. (NYSE:BVX) recorded profits of $4,236 on revenue of $6.5 million during the three months ended Sept. 30. That compares with a loss of $37.7 million on sales of $6.4 million during the same period last year.
Read more

Clinical Data losses ease
Clinical Data Inc. (NSDQ:CLDA) recorded a loss of $16.6 million, or 56 cents per diluted share, on sales of $3.4 million during the three months ended Sept. 30. That compares with a loss of $18.7 million, or 79 cents per diluted share, on sales of $3.0 million during the same period last year.
Read more

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well Tagged With: Accellent Inc., Angiotech, Bovie Medical Corp., Clinical Data Inc., Insulet, NMT Medical Inc., Theragenics Corp.

More recent news

  • Medtronic earns CE mark for redo TAVI procedure
  • Natus Neuro launches BrainWatch AI-driven, point-of-care EEG
  • Boston Scientific has positive real-world Acurate Prime TAVI data
  • Johnson & Johnson MedTech launches ultrasound catheter for imaging in cardiac ablation procedures
  • Onward reports more successful BCI implants

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy